Dr. Sylvester Omoruyi

Sylvester Omoruyi is a biomedical researcher whose work centers on natural product pharmacology, neuroprotection, and anticancer drug discovery. His scholarship integrates phytochemistry, cellular biology, and toxicology to investigate plant-derived compounds as therapeutic candidates. Drawing strongly on African medicinal flora, his research bridges traditional medicine and modern experimental models, advancing translational insights into disease prevention and treatment.

A major focus of his publications is neuroprotection in models of Parkinson’s disease, where extracts and isolated phytochemicals are shown to modulate oxidative stress, mitochondrial dysfunction, and apoptosis in neuronal cells. He has also explored green synthesis of nanoparticle systems and their biological activity, highlighting innovation at the interface of nanotechnology and phytochemistry. Complementary studies examine protective effects against neurotoxins and environmental toxicants.

Omoruyi’s work further addresses anticancer strategies, including investigations into glioblastoma and other tumor cell lines, emphasizing selective cytotoxicity and mitochondrial-mediated mechanisms. His recent contributions expand into developmental origins of disease and cancer risk, reflecting a broadening interest in prevention science. Collectively, his research demonstrates strength in bioactive compound isolation, mechanistic in vitro assays, and the valorization of medicinal plants for therapeutic development.